ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
dyode
|
18K |
6.6M |
1 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
18K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
0 |
06/08/25 |
06/08/25 |
ASX - By Stock
|
19K
|
8.4M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
1 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
19K
|
8.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
6 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
19K
|
8.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
dyode
|
18K |
6.6M |
9 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
18K
|
6.6M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
3 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
19K
|
8.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
7 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
19K
|
8.4M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
2 |
01/08/25 |
01/08/25 |
ASX - By Stock
|
19K
|
8.4M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
dyode
|
2.4K |
1.0M |
2 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
2.4K
|
1.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
8 |
27/07/25 |
27/07/25 |
ASX - By Stock
|
19K
|
8.4M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
dyode
|
2.4K |
1.0M |
0 |
27/07/25 |
27/07/25 |
ASX - By Stock
|
2.4K
|
1.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
dyode
|
2.4K |
1.0M |
3 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
2.4K
|
1.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
dyode
|
358 |
121K |
6 |
20/07/25 |
20/07/25 |
ASX - By Stock
|
358
|
121K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dyode
|
444 |
193K |
5 |
19/07/25 |
19/07/25 |
ASX - By Stock
|
444
|
193K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dyode
|
444 |
193K |
3 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
444
|
193K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dyode
|
444 |
193K |
9 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
444
|
193K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
dyode
|
444 |
193K |
9 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
444
|
193K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
6 |
18/07/25 |
18/07/25 |
ASX - By Stock
|
19K
|
8.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Isn't MSB an Australian company?
|
|
dyode
|
18 |
5.9K |
3 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
18
|
5.9K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
dyode
|
210 |
93K |
13 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
210
|
93K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
dyode
|
210 |
93K |
2 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
210
|
93K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
dyode
|
210 |
93K |
1 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
210
|
93K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
dyode
|
210 |
93K |
2 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
210
|
93K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Quarter 2 Ryoncil revenue projections
|
|
dyode
|
210 |
93K |
4 |
13/07/25 |
13/07/25 |
ASX - By Stock
|
210
|
93K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
5 |
08/07/25 |
08/07/25 |
ASX - By Stock
|
19K
|
8.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
dyode
|
358 |
121K |
21 |
04/07/25 |
04/07/25 |
ASX - By Stock
|
358
|
121K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MSB Broker Data
|
|
dyode
|
136 |
66K |
2 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
136
|
66K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
dyode
|
18K |
6.6M |
8 |
30/06/25 |
30/06/25 |
ASX - By Stock
|
18K
|
6.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast 2025: The year of acting like a publicly listed company
|
|
dyode
|
1.4K |
548K |
0 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
1.4K
|
548K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
3 |
25/06/25 |
25/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Maintains Momentum with FDA
|
|
dyode
|
246 |
120K |
19 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
246
|
120K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
dyode
|
358 |
121K |
4 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
358
|
121K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
dyode
|
358 |
121K |
3 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
358
|
121K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
dyode
|
358 |
121K |
0 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
358
|
121K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
dyode
|
358 |
121K |
3 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
358
|
121K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
2 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
1 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
15 |
15/06/25 |
15/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
1 |
14/06/25 |
14/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
22 |
14/06/25 |
14/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
dyode
|
18K |
6.6M |
3 |
09/06/25 |
09/06/25 |
ASX - By Stock
|
18K
|
6.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
dyode
|
18K |
6.6M |
1 |
09/06/25 |
09/06/25 |
ASX - By Stock
|
18K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
7 |
09/06/25 |
09/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
6 |
08/06/25 |
08/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
1 |
08/06/25 |
08/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
1 |
08/06/25 |
08/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
9 |
07/06/25 |
07/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
2 |
07/06/25 |
07/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
3 |
06/06/25 |
06/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
dyode
|
19K |
8.4M |
2 |
06/06/25 |
06/06/25 |
ASX - By Stock
|
19K
|
8.4M
|
2
|
|